Skip to main content

JANE STREET GROUP, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1595888 NEW YORK, NY

Position in XENE

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$201,664
+$201,664 QoQ
Shares Held
3,468
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Derivatives in XENE

reported options exposure · as of Mar 31, 2026
CallValue
$7,763,025
CallShares
133,500
PutValue
$12,351,060
PutShares
212,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. XENE ranks #225 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $201,664 3,468
2026-03-31 $12,351,060 212,400
2026-03-31 $7,763,025 133,500
2025-12-31 $887,436 19,800
2025-12-31 $233,064 5,200
2025-09-30 $2,858,680 71,200
2025-09-30 $3,608,641 89,879
2025-06-30 $644,780 20,600
2025-06-30 $1,367,058 43,676
2025-03-31 $811,910 24,200
2024-12-31 $436,609 11,138
2024-12-31 $364,560 9,300
2024-09-30 $1,984,248 50,400
2024-06-30 $575,297 14,755
2024-03-31 $363,729 8,449
2023-12-31 $1,353,702 29,390
2023-09-30 $836,201 24,479
2023-06-30 $335,604 8,717
2023-03-31 $202,786 5,666
2022-12-31 $602,883 15,290
2022-09-30 $1,513,022 41,912
2022-03-31 $492,696 16,117
2022-03-31 $632,799 20,700